Am J Transplant, Volume 5, Suppl 3 Archives - Page 64 of 170 - ATC Abstracts

2015 American Transplant Congress
Pediatric Liver Transplantation from Living Donors in Cali – Colombia
L. Caicedo, V. Botero, J. Villegas, O. Serrano, M. Duque, M. Valderrama, E. Manzi, M. Agudelo, G. Echeverri.
Transplant Unit, Fundacion Valle del Lili, Cali, Valle del Cauca, Colombia.
Introduction. Starting a pediatric liver transplant program in a developing country, is a great challenge, due to technical difficulties and increased morbidity and mortality, and…
2015 American Transplant Congress
Association of Transplant Volume and Survival in Pediatric Kidney Transplants
W. Cherikh,¹ A. Wilk,¹ C. Flavin,¹ E. Brewer.²
¹United Network for Organ Sharing, Richmond, VA; ²Baylor Coll Med & Texas Children's Hosp., Houston, TX.
Background. Center specific volume has been shown to correlate with outcomes for many procedures in the adult population. The current analysis was conducted to determine…
2015 American Transplant Congress
Successful Consolidation of Two Kidney/Pancreas Transplant Programs
D. Morgan, A. Tietjen, S. Mulgoankar.
Renal & Pancreas Transplant, Barnabas Health, Livingston.
The decision to consolidate two kidney/pancreas transplant programs within the same healthcare system and within a 10 mile radius, was a pro-active approach in an…
2015 American Transplant Congress
The Correlation Between Donor Specific Antibodies and Heart Transplant Rejection
R. Bedard,¹ P. Jindra,² M. Manson,¹ M. Moaddab,¹ H. Mallidi,³ W. Etheridge,¹ A. Civitello,³ R. Kerman.²
¹CHI St. Luke's Health - Baylor St. Luke's Medical Center, Houston, TX; ²Immune Evaluation Laboratory, Baylor College of Medicine, Houston, TX; ³Texas Heart Institute, Baylor College of Medicine, Houston, TX.
The presence of donor specific HLA antibodies (DSA) has been shown to be detrimental to heart transplant (HTx) survival. Virtual crossmatching (VXM) offers a rapid…
2015 American Transplant Congress
The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review
M. AlDabbagh,^1,2 M. Gitman,³ D. Kumar, A. Humar, C. Rotstein, S. Husain.^1,3
¹Medicine, Division of Infectious Diseases, University Health Network, Toronto, On, Canada; ²Pediatrics, Division of Infectious Diseases, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia; ³Multi-Organ Transplant Unit, University Health Network, Toronto, ON, Canada.
Background The role of antiviral prophylaxis in EBV seronegative solid organ transplant recipients receiving organs from seropositive donors for prevention of PTLD remains controversial. We…
2015 American Transplant Congress
Pre-Trasplant Perfusion With Mesenchymal Stromal Cells of Renal Graft Prevents Ischemia Injury Upregulating Gene Involved in Energy Saving
V. Corradetti,¹ S. Milanesi,¹ E. Pattonieri,¹ C. Rocca,¹ T. Valsania,¹ M. Gregorini,¹ L. De Cecco,² I. Benzoni,³ C. Bianco,³ M. Avanzini,⁴ M. Maestri,³ P. Esposito,¹ T. Rampino,¹ A. Dal Canton.
¹Unit of Nephrology, Dialysis and Transplantation, IRCCS Fondazione Policlinico San Matteo And University of Pavia, Pavia, Italy; ²Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy; ³Unit of General Surgery, IRCCS Fondazione Policlinico San Matteo And University of Pavia, Pavia, Italy; ⁴Cell Factory Pediatric Oncohaematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Background. Kidney ischemia from Donation after Circulatory Death shifts cells to anaerobic metabolism. Mesenchymal Stromal Cells (MSC) have immunomodulatory properties that are mediated by soluble…
2015 American Transplant Congress
Surgical Error: A Common, Preventable Threat to Deceased Donor Organs
A. Friedman,¹ T. Diflo,² S. Florman,³ L. Ratner,⁴ E. Marquez,¹ W. Tajik.¹
¹New York Organ Donor Network, New York, NY; ²Westchester Medical Center, Valhalla, NY; ³Mount Sinai School of Medicine, New York, NY; ⁴Columbia Presbyterian Medical Center, New York, NY.
Deceased donor procurements (N = 340) performed through a single organ procurement organization during a 19 month period from 7/1/13 - 11/30/14 were reviewed through…
2015 American Transplant Congress
Histology and Not Donor Specific Antibody Helps Predict 5-Year Kidney Transplant Failure Using 1 Year Post-Transplant Data
M. Moreno Gonzales,¹ A. Bentall,^2,3 M. Stegall,¹ R. Borrows.²
¹Department of Transplant Surgery, Mayo Clinic, Rochester, MN; ²Department of Nephrology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom; ³School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom.
Introduction: The objective of this study was to validate the RISK score (Am J Kid D 2014; 63[4]:643) for renal allograft failure using a different…
2015 American Transplant Congress
Is Transplant Volume Associated With Survival in Pediatric Liver Transplants?
W. Cherikh,¹ H. Kim,² A. Wilk,¹ C. Flavin,¹ E. Brewer.³
¹United Network for Organ Sharing, Richmond, VA; ²Boston Children's Hospital, Boston, MA; ³Baylor Coll Med & Texas Children's Hosp, Houston, TX.
Background. Center specific volume has been shown to correlate with outcomes for many procedures in the adult population. The current study was conducted to determine…
2015 American Transplant Congress
No Significant Outcome Benefit for Brand-Name Versus Generic Tacrolimus in Kidney Transplant Recipients: SRTR Analysis
D. Goldfarb,¹ E. Poggio,¹ S. Flechner,¹ R. Fatica,¹ J. Schold.²
¹Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH; ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.
IntroGeneric formulations of tacrolimus have been available for maintenance immunosuppression since 2009. Our aim was to evaluate the frequency of use of generic tacrolimus and…